Ontology highlight
ABSTRACT:
SUBMITTER: Conforti A
PROVIDER: S-EPMC8483992 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
Conforti Antonella A Marra Emanuele E Palombo Fabio F Roscilli Giuseppe G Ravà Micol M Fumagalli Valeria V Muzi Alessia A Maffei Mariano M Luberto Laura L Lione Lucia L Salvatori Erika E Compagnone Mirco M Pinto Eleonora E Pavoni Emiliano E Bucci Federica F Vitagliano Grazia G Stoppoloni Daniela D Pacello Maria Lucrezia ML Cappelletti Manuela M Ferrara Fabiana Fosca FF D'Acunto Emanuela E Chiarini Valerio V Arriga Roberto R Nyska Abraham A Di Lucia Pietro P Marotta Davide D Bono Elisa E Giustini Leonardo L Sala Eleonora E Perucchini Chiara C Paterson Jemma J Ryan Kathryn Ann KA Challis Amy-Rose AR Matusali Giulia G Colavita Francesca F Caselli Gianfranco G Criscuolo Elena E Clementi Nicola N Mancini Nicasio N Groß Rüdiger R Seidel Alina A Wettstein Lukas L Münch Jan J Donnici Lorena L Conti Matteo M De Francesco Raffaele R Kuka Mirela M Ciliberto Gennaro G Castilletti Concetta C Capobianchi Maria Rosaria MR Ippolito Giuseppe G Guidotti Luca G LG Rovati Lucio L Iannacone Matteo M Aurisicchio Luigi L
Molecular therapy : the journal of the American Society of Gene Therapy 20210920 1
The COVID-19 pandemic caused by SARS-CoV-2 has made the development of safe and effective vaccines a critical priority. To date, four vaccines have been approved by European and American authorities for preventing COVID-19, but the development of additional vaccine platforms with improved supply and logistics profiles remains a pressing need. Here we report the preclinical evaluation of a novel COVID-19 vaccine candidate based on the electroporation of engineered, synthetic cDNA encoding a viral ...[more]